Literature DB >> 7682302

Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve.

M Corbo1, A Quattrini, N Latov, A P Hays.   

Abstract

Anti-GM1 antibodies in patients with motor neuropathy or motor neuron disease frequently recognize the Gal(beta 1-3)GalNAc epitope, which is shared by several glycoproteins in peripheral nerve. In this study, cholera toxin (CT), which is specific for GM1, and the lectin peanut agglutinin (PNA), which binds to Gal(beta 1-3)GalNAc-bearing glycoproteins, were used in tissue section and intraneural injection studies to examine the distribution of GM1 and Gal(beta 1-3)GalNAc epitopes in human and rat peripheral nerve by epifluorescence and confocal microscopy. In tissue sections, CT stained the compact myelin in both human and rat nerves, whereas PNA was localized at the outer edge of the myelin sheath or Schwann cell membrane. Following intraneural injection into rat sciatic nerves, both CT and PNA bound to the nodes of Ranvier, although CT was concentrated in the paranodal myelin region whereas PNA was concentrated at the nodal gap. These structures may be targets for anti-GM1 antibodies in peripheral nerve.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682302     DOI: 10.1212/wnl.43.4.809

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Anti-GM1 antibodies in polyneuropathies of unknown origin.

Authors:  J Finsterer; W Muellbacher; W M Halbmayer; M Fischer; B Mamoli
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

Review 2.  Autoimmune responses in peripheral nerve.

Authors:  H P Hartung; H Willison; S Jung; M Pette; K V Toyka; G Giegerich
Journal:  Springer Semin Immunopathol       Date:  1996

3.  IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls.

Authors:  A S Bansal; B Abdul-Karim; R A Malik; P Goulding; R S Pumphrey; A J Boulton; P L Holt; P B Wilson
Journal:  J Clin Pathol       Date:  1994-04       Impact factor: 3.411

4.  Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides.

Authors:  J C Garcia-Monco; R J Seidman; J L Benach
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 5.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

6.  Molecular composition of the node of Ranvier: identification of ankyrin-binding cell adhesion molecules neurofascin (mucin+/third FNIII domain-) and NrCAM at nodal axon segments.

Authors:  J Q Davis; S Lambert; V Bennett
Journal:  J Cell Biol       Date:  1996-12       Impact factor: 10.539

7.  Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited.

Authors:  Katja Kollewe; Ulrich Wurster; Thomas Sinzenich; Sonja Körner; Reinhard Dengler; Bahram Mohammadi; Susanne Petri
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

Review 8.  Role of Gangliosides in Peripheral Pain Mechanisms.

Authors:  Péter Sántha; Ildikó Dobos; Gyöngyi Kis; Gábor Jancsó
Journal:  Int J Mol Sci       Date:  2020-02-03       Impact factor: 5.923

Review 9.  MMN: from immunological cross-talk to conduction block.

Authors:  Oliver Harschnitz; Bas A Jongbloed; Hessel Franssen; Dirk C G Straver; W Ludo van der Pol; Leonard H van den Berg
Journal:  J Clin Immunol       Date:  2014-04-13       Impact factor: 8.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.